Upstate Active Clinical Trials

Study Title:

NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

What is the purpose of the study? (in Layman's terms, please describe the study)

To examine if letrozole monotherapy/maintenance (L/L) is non-inferior to IV paclitaxel/carboplatin and maintenance letrozole (CT/L) with respect to PFS in women with stage II-IV primary low-grade serous carcinoma of the ovary or peritoneum after primary surgical cytoreduction.

Upstate Institutional Review Board (IRB) Number:

1694573

Study/Protocol ID:

NRG-GY019

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

What is involved if I participate?

• How long is the study?
  5 yrs
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  see protocol

Where will the study take place?

The Cancer Center - all procedures
Madison Irving - all procedures

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT04095364

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Sarah Clark, BS
Phone: 315-464-8276
Email: [email protected]

Return to Previous Page || Search Again